NAAA-IN-3
NAAA-IN-3 (Compound 17a) is a potent and selective inhibitor of NAAA with an IC50 of 50 nM. NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) . NAAA-IN-3 has the potential for the research of inflammation and pain[1].
Product Specifications
CAS Number
[1831115-59-3]
UNSPSC
12352005
Target
Ceramidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/naaa-in-3.html
Purity
98.20
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CN1CC(C1)OCC2=CC=C(C=C2)C3=CC=CC=C3
Molecular Formula
C17H16N2O
Molecular Weight
264.32
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147775/NAAA-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147775/NAAA-IN-3-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Human Transmembrane protein 175 (TMEM175), partial
Recombinant Human Transmembrane protein 175 (TMEM175), partial
Recombinant Human Transmembrane protein 175 (TMEM175), partial
Recombinant Human Transmembrane protein 175 (TMEM175), partial
Recombinant Human Transmembrane protein 175 (TMEM175), partial